Annual Shareholders Equity
$459.22 M
+$140.39 M+44.03%
December 31, 2024
Summary
- As of March 12, 2025, EWTX annual stockholders equity is $459.22 million, with the most recent change of +$140.39 million (+44.03%) on December 31, 2024.
- During the last 3 years, EWTX annual shareholders equity has risen by +$184.83 million (+67.36%).
- EWTX annual shareholders equity is now at all-time high.
Performance
EWTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$459.22 M
-$29.66 M-6.07%
December 31, 2024
Summary
- As of March 12, 2025, EWTX quarterly stockholders equity is $459.22 million, with the most recent change of -$29.66 million (-6.07%) on December 31, 2024.
- Over the past year, EWTX quarterly shareholders equity has dropped by -$29.66 million (-6.07%).
- EWTX quarterly shareholders equity is now -14.16% below its all-time high of $534.94 million, reached on March 31, 2024.
Performance
EWTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
EWTX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +44.0% | -6.1% |
| 3 y3 years | +67.4% | +58.1% |
| 5 y5 years | +2824.8% | +58.1% |
EWTX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +67.4% | -14.2% | +86.4% |
| 5 y | 5-year | at high | +1474.1% | -14.2% | +1474.1% |
| alltime | all time | at high | +1474.1% | -14.2% | +1474.1% |
Edgewise Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $459.22 M(+44.0%) | $459.22 M(-6.1%) |
| Sep 2024 | - | $488.88 M(-4.2%) |
| Jun 2024 | - | $510.47 M(-4.6%) |
| Mar 2024 | - | $534.94 M(+67.8%) |
| Dec 2023 | $318.83 M(-8.0%) | $318.83 M(+9.8%) |
| Sep 2023 | - | $290.43 M(-6.8%) |
| Jun 2023 | - | $311.45 M(-5.3%) |
| Mar 2023 | - | $328.84 M(-5.2%) |
| Dec 2022 | $346.72 M | $346.72 M(-4.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $361.40 M(+46.7%) |
| Jun 2022 | - | $246.35 M(-5.4%) |
| Mar 2022 | - | $260.36 M(-5.1%) |
| Dec 2021 | $274.38 M(-921.0%) | $274.38 M(-3.9%) |
| Sep 2021 | - | $285.40 M(-3.8%) |
| Jun 2021 | - | $296.75 M(-3.1%) |
| Mar 2021 | - | $306.39 M(-1016.8%) |
| Dec 2020 | -$33.42 M(+98.3%) | -$33.42 M |
| Dec 2019 | -$16.85 M | - |
FAQ
- What is Edgewise Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual shareholders equity year-on-year change?
- What is Edgewise Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly shareholders equity year-on-year change?
What is Edgewise Therapeutics annual stockholders equity?
The current annual shareholders equity of EWTX is $459.22 M
What is the all time high annual shareholders equity for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual stockholders equity is $459.22 M
What is Edgewise Therapeutics annual shareholders equity year-on-year change?
Over the past year, EWTX annual stockholders equity has changed by +$140.39 M (+44.03%)
What is Edgewise Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of EWTX is $459.22 M
What is the all time high quarterly shareholders equity for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly stockholders equity is $534.94 M
What is Edgewise Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, EWTX quarterly stockholders equity has changed by -$29.66 M (-6.07%)